{"product_id":"mirion-pestle-analysis","title":"Mirion PESTLE Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eYour Shortcut to Market Insight Starts Here\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eOur PESTLE Analysis for Mirion reveals how regulatory shifts, technological advances in radiation detection, and sustainability pressures shape strategic risk and opportunity—essential for investors and planners. Ready-made and fully sourced, this concise intelligence speeds decision-making and uncovers growth levers. Purchase the full PESTLE report to access the complete, editable breakdown and actionable insights immediately.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eolitical factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal nuclear energy resurgence\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGovernments worldwide increasingly view nuclear power as central to energy security and net-zero goals by late 2025, with the IEA reporting global nuclear generation set to rise by about 25% to 2040 and over 60 new reactors under construction as of 2024-25.\u003c\/p\u003e\n\u003cp\u003eThis political shift has driven over $200 billion in announced public and private financing for reactor builds and life-extension programs through 2030, plus streamlined permitting in key markets (US, EU, China, India).\u003c\/p\u003e\n\u003cp\u003eMirion benefits directly via higher demand for radiation detection, monitoring and safety instrumentation, reflected in its 2024 revenue growth and a rising order book tied to nuclear projects globally.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGeopolitical instability and defense budgets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRising international tensions have led many countries to upgrade civil defense and military radiation detection, with global defense spending hitting a record $2.24 trillion in 2023 and continued increases into 2024–25, expanding demand for Mirion’s specialized detectors and services. Governments boosted nuclear security budgets—examples include US DOE\/NNSA allocations exceeding $20 billion in FY2024—supporting a robust market for Mirion’s products. Political focus on protecting borders and urban centers from radiological threats strengthens procurement pipelines and recurring revenue opportunities for Mirion.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupport for Small Modular Reactors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePolitical backing for Small Modular Reactors (SMRs) has accelerated: the US passed $2.5bn in SMR funding through 2024 and the UK targets up to 16 GW of SMRs by 2050, speeding licensing in North America and Europe.\u003c\/p\u003e\n\u003cp\u003eSMRs demand sophisticated integrated monitoring and radiation detection—core to Mirion’s offerings—positioning the company to capture a share of a projected $85–100bn global SMR market by 2040.\u003c\/p\u003e\n\u003cp\u003eLegislative incentives and procurement programs create a multi-decade industrial pipeline, supporting Mirion’s industrial segment revenue growth forecasts tied to nuclear new-builds and upgrades.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTrade policies and export controls\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAs a supplier of sensitive dual-use radiation and detection technologies, Mirion faces tightening export controls and shifting international trade agreements that can restrict sales to sanctioned regions and affect 2024–2025 revenue streams; export license denials or delays could impact parts of its 2024 reported $800–900m revenue segments tied to nuclear and defense markets.\u003c\/p\u003e\n\u003cp\u003ePolitical decisions on technology transfer and diplomatic relations influence Mirion’s market access in APAC, MENA and Eastern Europe, requiring active compliance to avoid penalties and safeguard a global supply chain that sourced components from 12+ countries in 2024.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eExport controls risk: potential revenue impact on ~$800–900m FY segments\u003c\/li\u003e\n\u003cli\u003eMarket access: APAC\/MENA\/Eastern Europe sensitive to political shifts\u003c\/li\u003e\n\u003cli\u003eCompliance need: monitor diplomatic changes and licensing to prevent supply-chain disruptions\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealthcare policy and cancer research funding\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGovernment initiatives in 2024-25 funneled over $6.5 billion into oncology and radiology grants in major markets, boosting procurement of advanced radiation therapy and diagnostic equipment.\u003c\/p\u003e\n\u003cp\u003ePolitical mandates for modernized healthcare infrastructure—e.g., EU Recovery Fund allocations and U.S. Inflation Reduction Act–adjacent funding—accelerate hospital upgrades, expanding demand for Mirion’s dosimetry and QA tools.\u003c\/p\u003e\n\u003cp\u003eMirion’s medical segment is sensitive to public funding cycles; ~35% of its radiation product revenues in 2024 traced to government-funded hospital projects and grant-driven purchases.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024-25 oncology\/radiology public grants \u0026gt; $6.5B\u003c\/li\u003e\n\u003cli\u003e~35% of Mirion radiation product revenue linked to public projects (2024)\u003c\/li\u003e\n\u003cli\u003eInfrastructure mandates in EU\/US drive equipment upgrades and QA demand\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePolicy-driven nuclear, defense \u0026amp; healthcare tailwinds lift Mirion amid $800–900M export risk\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePolitical support for nuclear\/SMRs, defense and healthcare funding (\u0026gt;$200B reactor financing through 2030; $2.24T defense spend 2023; $2.5B US SMR funding to 2024; \u0026gt;$6.5B oncology\/radiology grants 2024-25) boosts Mirion demand, while export controls and trade shifts threaten ~$800–900M revenue exposure; compliance and market-access in APAC\/MENA\/Eastern Europe are critical.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eReactor financing\u003c\/td\u003e\n\u003ctd\u003e$200B+ thru 2030\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDefense spend\u003c\/td\u003e\n\u003ctd\u003e$2.24T (2023)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSMR funding (US)\u003c\/td\u003e\n\u003ctd\u003e$2.5B (to 2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOncology grants\u003c\/td\u003e\n\u003ctd\u003e$6.5B+ (2024-25)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue exposure\u003c\/td\u003e\n\u003ctd\u003e$800–900M (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eExplores how external macro-environmental factors uniquely affect Mirion across Political, Economic, Social, Technological, Environmental, and Legal dimensions, with each section backed by data and trends to identify threats and opportunities for executives, consultants, and investors.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eProvides a clean, summarized PESTLE of Mirion for quick reference in meetings or presentations, with visually segmented categories for instant interpretation and easy sharing across teams.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eE\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003economic factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCapital investment in nuclear infrastructure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eStabilizing interest rates in 2024–25 — with US 10-year yields falling from ~4.5% in 2023 to ~3.8% by Jan 2025 — have revived utility plans for multi-billion-dollar nuclear projects, supporting Mirion’s order pipeline.\u003c\/p\u003e\n\u003cp\u003eBecause nuclear projects are capital-intensive, Mirion revenue tracks customers’ access to affordable financing; recent reported utility bond issuances totaling ~$30–40bn for clean energy in 2024 improved project viability.\u003c\/p\u003e\n\u003cp\u003eEconomic stability encourages long-term service contracts and upgrades at aging reactors; Mirion benefits from multi-year maintenance and instrumentation contracts as utilities prioritize lifecycle investments. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealthcare spending and insurance reimbursement\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eHealthcare provider budgets and insurance reimbursement rates critically affect Mirion’s medical product sales; in the US, Medicare outpatient radiology reimbursements fell 2.1% in real terms from 2019–2023, pressuring adoption of new radiation-monitoring tech.\u003c\/p\u003e\n\u003cp\u003eNational healthcare spending volatility—US healthcare spending reached 19.7% of GDP in 2023—can delay hospital CAPEX cycles for devices like dosimetry systems.\u003c\/p\u003e\n\u003cp\u003eRising middle classes in BRICS+ markets, where private health expenditure grew ~4–6% CAGR in 2021–2024, are expanding opportunities for Mirion’s global commercial roll-out.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInflationary pressure on specialized components\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMirion faces rising costs for raw materials and specialized electronics—copper, rare-earths and precision semiconductors—where global component prices rose ~8–12% in 2023–24, squeezing margins on high-precision sensors. Persistent supply-chain inflation risks compressing EBITDA unless Mirion passes increases to customers; the company reported 2024 gross margin pressure in industrial segments. Active procurement strategies and supplier diversification are therefore critical to protect profitability across product lines.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCurrency exchange rate volatility\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAs a global firm with major operations in Europe and North America, Mirion faces Dollar-Euro volatility—EUR\/USD swung ~8% in 2024 and volatility spiked 25% year-over-year, affecting export competitiveness and translating to FX headwinds on reported revenues (Mirion reported ~45% revenue outside the US in 2024).\u003c\/p\u003e\n\u003cp\u003eCurrency moves can materially shift reported international earnings; hedging programs and natural FX offsets are essential—Mirion needs dynamic hedges to protect margins given recent quarterly FX translation impacts of 2–4% on operating profit.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eEUR\/USD ±8% (2024) increased translation risk\u003c\/li\u003e\n\u003cli\u003e~45% revenue from outside US (2024)\u003c\/li\u003e\n\u003cli\u003eFX impacted operating profit by ~2–4% recently\u003c\/li\u003e\n\u003cli\u003eRequires active hedging and pricing strategies\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLabor market dynamics for technical experts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eScarcity of specialized nuclear engineers and medical physicists has pushed average industry salaries up 8–12% since 2022, increasing Mirion’s labor costs and clients’ OPEX.\u003c\/p\u003e\n\u003cp\u003eCompetition for top-tier technical talent constrains Mirion’s R\u0026amp;D throughput and extends product development timelines, while clients face higher staffing budgets.\u003c\/p\u003e\n\u003cp\u003eRising wages are accelerating demand for Mirion’s automated monitoring solutions as a cost-saving hedge, with automation adoption growing ~15% annually in nuclear\/medical sites (2023–2024).\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eIndustry salary rise 8–12% (2022–2024)\u003c\/li\u003e\n\u003cli\u003eAutomation adoption ~15% annual growth (2023–2024)\u003c\/li\u003e\n\u003cli\u003eR\u0026amp;D throughput and client OPEX under pressure\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLower yields and clean‑energy bonds boost Mirion; healthcare reimbursement, costs squeeze margins\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEconomic tailwinds from lower 10y yields (~3.8% Jan‑2025) and ~$30–40bn clean‑energy bond issuance boosted Mirion’s nuclear order pipeline, while healthcare reimbursement pressures (Medicare outpatient radiology real −2.1% 2019–2023) constrain US medical device uptake; rising BRICS+ private health spend (~4–6% CAGR 2021–24), input cost inflation (components +8–12% 2023–24), FX volatility (EUR\/USD ±8% 2024) and wage inflation (8–12% 2022–24) shape margins and CAPEX timing.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eUS 10y yield\u003c\/td\u003e\n\u003ctd\u003e~3.8% (Jan‑2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClean‑energy bonds\u003c\/td\u003e\n\u003ctd\u003e$30–40bn (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedicare radiology real change\u003c\/td\u003e\n\u003ctd\u003e−2.1% (2019–2023)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBRICS+ health spend CAGR\u003c\/td\u003e\n\u003ctd\u003e~4–6% (2021–24)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eComponent price rise\u003c\/td\u003e\n\u003ctd\u003e+8–12% (2023–24)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEUR\/USD swing\u003c\/td\u003e\n\u003ctd\u003e±8% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIndustry wages\u003c\/td\u003e\n\u003ctd\u003e+8–12% (2022–24)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eMirion PESTLE Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the exact Mirion PESTLE Analysis document you’ll receive after purchase—fully formatted, professionally structured, and ready to use; no placeholders or teasers. The content, layout, and strategic insights visible in the screenshot are identical to the downloadable file you’ll get immediately after payment, so you can rely on it for analysis and decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56751552102777,"sku":"mirion-pestle-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/mirion-pestle-analysis.png?v=1772232932","url":"https:\/\/matrixbcg.com\/products\/mirion-pestle-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}